Hosts: Vincent Racaniello, Alan Dove, and Rich Condit On episode #116 of the podcast This Week in Virology, Vincent, Dickson, Alan, and Rich review an adenovirus-based vaccine strategy against drug addiction, a field trial of RNAi to prevent Israeli acute paralysis virus infection in honeybees, and suppression of avian influenza transmission in transgenic chickens. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV116.mp3″] Click the …
Hosts: Vincent Racaniello, Alan Dove, and Rich Condit On episode #114 of the podcast This Week in Virology, Vincent, Alan, and Rich revisit ten compelling virology stories of 2010. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV114.mp3″] Click the arrow above to play, or right-click to download TWiV #114 (64 MB .mp3, 88 minutes). Subscribe to TWiV (free) in iTunes , at the Zune Marketplace, by …
Influenza researcher Peter Palese visited yesterday and spoke about “Pandemic influenza: Past and Future”. A key part of his talk was a review of his efforts to produce a universal influenza vaccine which protects against all strains. He used the following graph to make the point that when influenza pandemic strains emerge, there is insufficient …
After my lecture on influenza pathogenesis and evolution at the Northeast Laboratory Conference 2010 in Portland, Maine, I was asked if it is necessary to receive the influenza vaccine every year. This question was precipitated by my statement that the 2010-11 trivalent influenza vaccine contains the same swine-origin H1N1 strain as last year€™s monovalent vaccine. …
Hosts: Vincent Racaniello, Alan Dove, and LJ Tan On Episode 103 of the podcast This Week in Virology, Vincent and Alan discuss influenza vaccines with LJ Tan of the American Medical Association. [powerpress url=”http://traffic.libsyn.com/twiv/TWiV103.mp3″] Click the arrow above to play, or right-click to download TWiV #103 (56 MB .mp3, 77 minutes) Subscribe to TWiV (free) in …
The need to re-formulate the influenza virus vaccine in response to viral antigenic drift and shift makes for complex logistics of vaccine production and administration. Surveillance programs must be conducted each year to identify strains that are likely to predominate and cause disease. Wouldn€™t it be simpler if a single vaccine could be developed that …
